Skip to main content
Top
Published in: Inflammation 6/2018

01-12-2018 | ORIGINAL ARTICLE

Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells

Authors: Yoshitaka Hosokawa, Ikuko Hosokawa, Kazumi Ozaki, Takashi Matsuo

Published in: Inflammation | Issue 6/2018

Login to get access

Abstract

Honokiol and magnolol, which are lignans isolated from Magnolia quinquepeta, have some pharmacological effects. However, the anti-inflammatory effects of honokiol and magnolol on periodontal disease are still uncertain. The aim of this study was to examine the effect of honokiol and magnolol on CXC chemokine receptor 3 (CXCR3) ligands, which are related with Th1 cell migration, production in interleukin (IL)-27-stimulated human oral epithelial cells (TR146 cells). Honokiol and magnolol inhibited CXC chemokine ligand (CXCL)10 and CXCL11 production in IL-27-stimulated TR146 cells in a dose-dependent manner. Moreover, we revealed that honokiol and magnolol could suppress signal transducer and activator of transcription (STAT)3 and protein kinase B (Akt) phosphorylation in IL-27-stimulated TR146 cells though STAT1 phosphorylation was not suppressed by honokiol and magnolol treatment. Furthermore, STAT3 and Akt inhibitors could suppress CXCR3 ligand production in TR146 cells. In summary, honokiol and magnolol could reduce CXCR3 ligand production in oral epithelial cell by inhibiting STAT3 and Akt activation.
Literature
1.
go back to reference Lee, Y.J., Y.M. Lee, C.K. Lee, J.K. Jung, S.B. Han, and J.T. Hong. 2011. Therapeutic applications of compounds in the Magnolia family. Pharmacology & Therapeutics 130: 157–176.CrossRef Lee, Y.J., Y.M. Lee, C.K. Lee, J.K. Jung, S.B. Han, and J.T. Hong. 2011. Therapeutic applications of compounds in the Magnolia family. Pharmacology & Therapeutics 130: 157–176.CrossRef
2.
go back to reference Xu, H.L., W. Tang, G.H. Du, and N. Kokudo. 2011. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discoveries &Therapeutics 5: 202–210.CrossRef Xu, H.L., W. Tang, G.H. Du, and N. Kokudo. 2011. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discoveries &Therapeutics 5: 202–210.CrossRef
3.
go back to reference Amorati, R., J. Zotova, A. Baschieri, and L. Valgimigli. 2015. Antioxidant activity of magnolol and honokiol: kinetic and mechanistic investigations of their reaction with peroxyl radicals. The Journal of Organic Chemistry 80: 10651–10659.CrossRef Amorati, R., J. Zotova, A. Baschieri, and L. Valgimigli. 2015. Antioxidant activity of magnolol and honokiol: kinetic and mechanistic investigations of their reaction with peroxyl radicals. The Journal of Organic Chemistry 80: 10651–10659.CrossRef
4.
go back to reference Amblard, F., B. Govindarajan, B. Lefkove, K.L. Rapp, M. Detorio, J.L. Arbiser, and R.F. Schinazi. 2007. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorganic & Medicinal Chemistry Letters 17: 4428–4431.CrossRef Amblard, F., B. Govindarajan, B. Lefkove, K.L. Rapp, M. Detorio, J.L. Arbiser, and R.F. Schinazi. 2007. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorganic & Medicinal Chemistry Letters 17: 4428–4431.CrossRef
5.
go back to reference Fu, S., C. Sun, X. Tao, and Y. Ren. 2012. Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Natural Product Research 26: 1746–1749.CrossRef Fu, S., C. Sun, X. Tao, and Y. Ren. 2012. Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Natural Product Research 26: 1746–1749.CrossRef
6.
go back to reference Hajishengallis, G. 2014. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends in Immunology 35: 3–11.CrossRef Hajishengallis, G. 2014. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends in Immunology 35: 3–11.CrossRef
7.
go back to reference Kawai, T., R. Eisen-Lev, M. Seki, J.W. Eastcott, M.E. Wilson, and M.A. Taubman. 2000. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. Journal of Immunology 164: 2102–2109.CrossRef Kawai, T., R. Eisen-Lev, M. Seki, J.W. Eastcott, M.E. Wilson, and M.A. Taubman. 2000. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. Journal of Immunology 164: 2102–2109.CrossRef
8.
go back to reference Taubman, M.A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12: 125–135.CrossRef Taubman, M.A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12: 125–135.CrossRef
9.
go back to reference Hosokawa, Y., I. Hosokawa, K. Ozaki, and T. Matsuo. 2017. IL-27 modulates chemokine production in TNF-α-stimulated human oral epithelial cells. Cellular Physiology and Biochemistry 43: 1198–1206.CrossRef Hosokawa, Y., I. Hosokawa, K. Ozaki, and T. Matsuo. 2017. IL-27 modulates chemokine production in TNF-α-stimulated human oral epithelial cells. Cellular Physiology and Biochemistry 43: 1198–1206.CrossRef
10.
go back to reference Han, J.J., M.P. Liu, Y. Jin, D.X. Liu, X. Fang, and X.P. Lin. 2013. Comparison of the IL-27 level in gingival crevicular fluid of cross-quadrant and the upper and lower half-mouth subgingival scaling. Shanghai Kou Qiang Yi Xue 22 (4): 428–431.PubMed Han, J.J., M.P. Liu, Y. Jin, D.X. Liu, X. Fang, and X.P. Lin. 2013. Comparison of the IL-27 level in gingival crevicular fluid of cross-quadrant and the upper and lower half-mouth subgingival scaling. Shanghai Kou Qiang Yi Xue 22 (4): 428–431.PubMed
11.
go back to reference Jacobsen, J., E.B. Nielsen, K. Brøndum-Nielsen, M.E. Christensen, H.B. Olin, N. Tommerup, and M.R. Rassing. 1999. Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability. European Journal of Oral Sciences 107: 138–146.CrossRef Jacobsen, J., E.B. Nielsen, K. Brøndum-Nielsen, M.E. Christensen, H.B. Olin, N. Tommerup, and M.R. Rassing. 1999. Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability. European Journal of Oral Sciences 107: 138–146.CrossRef
12.
go back to reference Diegelmann, J., T. Olszak, B. Göke, R.S. Blumberg, and S. Brand. 2012. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. The Journal of Biological Chemistry 287: 286–298.CrossRef Diegelmann, J., T. Olszak, B. Göke, R.S. Blumberg, and S. Brand. 2012. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. The Journal of Biological Chemistry 287: 286–298.CrossRef
13.
go back to reference Valverde, P., T. Kawai, and M.A. Taubman. 2004. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. Journal of Bone and Mineral Research 19: 155–164.CrossRef Valverde, P., T. Kawai, and M.A. Taubman. 2004. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. Journal of Bone and Mineral Research 19: 155–164.CrossRef
14.
go back to reference Hosokawa, I., Y. Hosokawa, S. Shindo, K. Ozaki, and T. Matsuo. 2016. Melatonin inhibits CXCL10 and MMP-1 production in IL-1β-stimulated human periodontal ligament cells. Inflammation 39: 1520–1526.CrossRef Hosokawa, I., Y. Hosokawa, S. Shindo, K. Ozaki, and T. Matsuo. 2016. Melatonin inhibits CXCL10 and MMP-1 production in IL-1β-stimulated human periodontal ligament cells. Inflammation 39: 1520–1526.CrossRef
15.
go back to reference Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2010. TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gamma-stimulated human gingival fibroblasts. Molecular Immunology 47: 666–670.CrossRef Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2010. TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gamma-stimulated human gingival fibroblasts. Molecular Immunology 47: 666–670.CrossRef
16.
go back to reference Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, and T. Matsuo. 2017. IL-29 enhances CXCL10 production in TNF-α-stimulated human oral epithelial cells. Immunological Investigations 46: 615–624.CrossRef Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, and T. Matsuo. 2017. IL-29 enhances CXCL10 production in TNF-α-stimulated human oral epithelial cells. Immunological Investigations 46: 615–624.CrossRef
17.
go back to reference Ho, K.Y., C.C. Tsai, C.P. Chen, J.S. Huang, and C.C. Lin. 2001. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytotherapy Research 15: 139–141.CrossRef Ho, K.Y., C.C. Tsai, C.P. Chen, J.S. Huang, and C.C. Lin. 2001. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytotherapy Research 15: 139–141.CrossRef
18.
go back to reference Lu, S.H., R.Y. Huang, and T.C. Chou. 2013. Magnolol ameliorates ligature-induced periodontitis in rats and osteoclastogenesis: in vivo and in vitro study. Evidence-based Complementary and Alternative Medicine 2013: 634095.PubMedPubMedCentral Lu, S.H., R.Y. Huang, and T.C. Chou. 2013. Magnolol ameliorates ligature-induced periodontitis in rats and osteoclastogenesis: in vivo and in vitro study. Evidence-based Complementary and Alternative Medicine 2013: 634095.PubMedPubMedCentral
19.
go back to reference Cao, J., C.K. Wong, Y. Yin, and C.W. Lam. 2010. Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-alpha: implications for immunopathophysiology of airway inflammation. Journal of Cellular Physiology 223: 788–797.PubMed Cao, J., C.K. Wong, Y. Yin, and C.W. Lam. 2010. Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-alpha: implications for immunopathophysiology of airway inflammation. Journal of Cellular Physiology 223: 788–797.PubMed
20.
go back to reference Rajendran, P., F. Li, M.K. Shanmugam, S. Vali, T. Abbasi, S. Kapoor, K.S. Ahn, A.P. Kumar, and G. Sethi. 2012. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. Journal of Cellular Physiology 227: 2184–2195.CrossRef Rajendran, P., F. Li, M.K. Shanmugam, S. Vali, T. Abbasi, S. Kapoor, K.S. Ahn, A.P. Kumar, and G. Sethi. 2012. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. Journal of Cellular Physiology 227: 2184–2195.CrossRef
21.
go back to reference Yu, C., Q. Zhang, H.Y. Zhang, X. Zhang, X. Huo, E. Cheng, D.H. Wang, J.L. Arbiser, S.J. Spechler, and R.F. Souza. 2012. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett’s cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 303: G561–G569.CrossRef Yu, C., Q. Zhang, H.Y. Zhang, X. Zhang, X. Huo, E. Cheng, D.H. Wang, J.L. Arbiser, S.J. Spechler, and R.F. Souza. 2012. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett’s cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 303: G561–G569.CrossRef
22.
go back to reference Kim, B.H., and J.Y. Cho. 2008. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacologica Sinica 29: 113–122.CrossRef Kim, B.H., and J.Y. Cho. 2008. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacologica Sinica 29: 113–122.CrossRef
23.
go back to reference Kim, K.M., N.S. Kim, J. Kim, J.S. Park, J.M. Yi, J. Lee, and O.S. Bang. 2013. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Nutrition and Cancer 65: 1245–1253.CrossRef Kim, K.M., N.S. Kim, J. Kim, J.S. Park, J.M. Yi, J. Lee, and O.S. Bang. 2013. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Nutrition and Cancer 65: 1245–1253.CrossRef
24.
go back to reference Lee, D.H., M.J. Szczepanski, and Y.J. Lee. 2009. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. Journal of Cellular Biochemistry 106: 1113–1122.CrossRef Lee, D.H., M.J. Szczepanski, and Y.J. Lee. 2009. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. Journal of Cellular Biochemistry 106: 1113–1122.CrossRef
25.
go back to reference Chen, S.C., Y.L. Chang, D.L. Wang, and J.J. Cheng. 2006. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. British Journal of Pharmacology 148: 226–232.CrossRef Chen, S.C., Y.L. Chang, D.L. Wang, and J.J. Cheng. 2006. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. British Journal of Pharmacology 148: 226–232.CrossRef
26.
go back to reference Chilampalli, C., R. Guillermo, X. Zhang, R.S. Kaushik, A. Young, D. Zeman, M.B. Hildreth, H. Fahmy, and C. Dwivedi. 2011. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action. BMC Cancer 11: 456.CrossRef Chilampalli, C., R. Guillermo, X. Zhang, R.S. Kaushik, A. Young, D. Zeman, M.B. Hildreth, H. Fahmy, and C. Dwivedi. 2011. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action. BMC Cancer 11: 456.CrossRef
Metadata
Title
Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells
Authors
Yoshitaka Hosokawa
Ikuko Hosokawa
Kazumi Ozaki
Takashi Matsuo
Publication date
01-12-2018
Publisher
Springer US
Published in
Inflammation / Issue 6/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0854-z

Other articles of this Issue 6/2018

Inflammation 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.